May 07, 2025 / 09:00AM GMT
Britt Meelby Jensen - Ambu A/S-Chief Executive Officer - Member of the Executive Board
Hello everyone and welcome to today's conference call with Ambu where we are going to announce and talk about our results from Q2 and the first half of our fiscal year 2024-2025. My name is Britt Meelby Jensen. I'm the CEO of Ambu, and with me today I have the pleasure of introducing Henrik Skak Bender, our CFO.
We will start with the presentation of the results, and then we will open up the floor for questions. But let me start with the highlights and the key messages that we have. If we look at the first half of our fiscal year, we delivered a solid organic revenue growth, bringing our first half of the year up to a total organic revenue growth of 15.4%. This is in line with our own expectations and in line with our adjusted guidance from January.
Also, we had a strong start on our very important launch Ambu SureSight Connect, and we continue good momentum on our urology launches when it comes to our aScope 5 Cysto HD and our aScope. I will come back later
Q2 2025 Ambu A/S Earnings Call Transcript
May 07, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers